A detailed history of Foundation Resource Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Foundation Resource Management Inc holds 574,223 shares of PFE stock, worth $15.1 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares
574,223
Previous 575,672 0.25%
Holding current value
$15.1 Million
Previous $16.1 Million 3.17%
% of portfolio
2.57%
Previous 2.57%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$27.7 - $31.39 $40,137 - $45,484
-1,449 Reduced 0.25%
574,223 $16.6 Million
Q2 2024

Jul 10, 2024

BUY
$25.26 - $29.6 $34,681 - $40,640
1,373 Added 0.24%
575,672 $16.1 Million
Q1 2024

Apr 11, 2024

BUY
$25.89 - $29.73 $136,492 - $156,736
5,272 Added 0.93%
574,299 $15.9 Million
Q4 2023

Jan 10, 2024

BUY
$26.13 - $33.94 $2.58 Million - $3.35 Million
98,580 Added 20.95%
569,027 $16.4 Million
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $74,224 - $86,760
-2,313 Reduced 0.49%
470,447 $15.6 Million
Q2 2023

Jul 12, 2023

BUY
$36.12 - $41.79 $2.66 Million - $3.08 Million
73,643 Added 18.45%
472,760 $17.3 Million
Q1 2023

Apr 11, 2023

BUY
$39.39 - $51.28 $59,912 - $77,996
1,521 Added 0.38%
399,117 $16.3 Million
Q4 2022

Jan 12, 2023

SELL
$41.75 - $54.5 $31,479 - $41,093
-754 Reduced 0.19%
397,596 $20.4 Million
Q3 2022

Oct 13, 2022

BUY
$43.76 - $53.42 $149,702 - $182,749
3,421 Added 0.87%
398,350 $17.4 Million
Q2 2022

Jul 15, 2022

SELL
$46.53 - $55.17 $62,210 - $73,762
-1,337 Reduced 0.34%
394,929 $20.7 Million
Q1 2022

Apr 12, 2022

SELL
$45.75 - $56.69 $195,810 - $242,633
-4,280 Reduced 1.07%
396,266 $20.5 Million
Q4 2021

Jan 21, 2022

SELL
$41.32 - $61.25 $16.6 Million - $24.5 Million
-400,546 Reduced 50.0%
400,546 $23.7 Million
Q4 2021

Jan 12, 2022

BUY
$41.32 - $61.25 $16.3 Million - $24.2 Million
394,396 Added 96.98%
801,092 $47.3 Million
Q3 2021

Oct 12, 2021

SELL
$39.25 - $50.42 $55,499 - $71,293
-1,414 Reduced 0.35%
406,696 $17.5 Million
Q2 2021

Jul 13, 2021

SELL
$35.91 - $40.68 $319,060 - $361,441
-8,885 Reduced 2.13%
408,110 $16 Million
Q1 2021

Apr 08, 2021

BUY
$33.49 - $37.77 $1.02 Million - $1.16 Million
30,584 Added 7.91%
416,995 $15.1 Million
Q4 2020

Jan 13, 2021

SELL
$33.47 - $42.56 $91,707 - $116,614
-2,740 Reduced 0.7%
386,411 $14.2 Million
Q3 2020

Oct 07, 2020

SELL
$31.75 - $37.25 $362,458 - $425,246
-11,416 Reduced 2.85%
389,151 $14.3 Million
Q2 2020

Jul 08, 2020

SELL
$30.12 - $36.54 $331,952 - $402,707
-11,021 Reduced 2.68%
400,567 $13.1 Million
Q1 2020

Apr 08, 2020

SELL
$27.03 - $38.62 $2.46 Million - $3.52 Million
-91,130 Reduced 18.13%
411,588 $13.4 Million
Q4 2019

Jan 08, 2020

SELL
$32.92 - $37.36 $183,561 - $208,319
-5,576 Reduced 1.1%
502,718 $19.7 Million
Q3 2019

Oct 03, 2019

SELL
$32.49 - $42.13 $234,122 - $303,588
-7,206 Reduced 1.4%
508,294 $18.3 Million
Q2 2019

Jul 10, 2019

SELL
$36.98 - $41.52 $116,191 - $130,455
-3,142 Reduced 0.61%
515,500 $22.3 Million
Q1 2019

Apr 11, 2019

SELL
$37.5 - $41.2 $748,350 - $822,187
-19,956 Reduced 3.71%
518,642 $22 Million
Q4 2018

Jan 17, 2019

SELL
$38.47 - $43.86 $12,310 - $14,035
-320 Reduced 0.06%
538,598 $23.5 Million
Q3 2018

Oct 02, 2018

SELL
$34.47 - $41.81 $7.27 Million - $8.82 Million
-210,923 Reduced 28.13%
538,918 $23.8 Million
Q2 2018

Jul 11, 2018

SELL
$32.98 - $35.16 $148,047 - $157,833
-4,489 Reduced 0.6%
749,841 $27.2 Million
Q1 2018

Apr 19, 2018

SELL
$31.91 - $37.02 $16 Million - $18.6 Million
-502,037 Reduced 39.96%
754,330 $26.8 Million
Q4 2017

Jan 10, 2018

SELL
$33.26 - $35.29 $6 Million - $6.37 Million
-180,501 Reduced 12.56%
1,256,367 $45.5 Million
Q3 2017

Oct 11, 2017

BUY
$31.0 - $34.15 $44.5 Million - $49.1 Million
1,436,868
1,436,868 $51.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Foundation Resource Management Inc Portfolio

Follow Foundation Resource Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundation Resource Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foundation Resource Management Inc with notifications on news.